A collaborative intervention model involving a clinical pharmacist significantly reduces severe hypoglycemia risk without compromising glycemic control.
Obesity and type 2 diabetes are deeply interconnected. Yet, many diabetes prevention programs fail to adequately treat ...
Ozempic is intended to help people with diabetes manage blood sugar. A dietitian breaks down exactly what Ozempic is, and if ...
The American Diabetes Association® (ADA) is pleased to announce this year's National Scientific and Health Care Achievement Award recipients. The awards honor academics, clinicians, and educators who ...
Advances in technology and treatment are making it easier for people with diabetes to get better life insurance rates ...
Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...
GLP-1 receptor agonists may increase the risk of bone and tendon injuries, as well as conditions like osteoporosis and gout, a retrospective study suggested. (Washington Post) Chairside HbA1c testing ...
Finerenone has been shown to reduce urinary albumin excretion in adults with type 1 diabetes and chronic kidney disease (CKD) ...
Israel: Glucagon-like peptide-1 receptor agonists (GLP-1RAs), widely used for their glycemic and cardiovascular benefits in type 2 diabetes, may be linked to a modestly higher risk of fragility ...
People on GLP-1s had slightly higher risks of osteoporosis and gout than similar people not taking these drugs. But diet and ...
High‑fibre foods: Enhance gut health, fullness and glucose control. Examples include oats, whole grains, beans, vegetables, ...
Objectives To evaluate whether type 2 diabetes mellitus (T2DM) presence and severity are associated with differences in global and domain-specific cognitive function among US adults, using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results